Search concepts
|
Selected Filters
|
- 25 - 50 out of 139 results
Search results
-
Active
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
MRI Guided PAD Imaging
Roy, T., Karmonik, C., Lumsden, A. B. & Peden, E. K.
11/19/20 → …
Project: Clinical Trial
-
Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of AL001 in FTD (AL001-3) (INFRONT-3)
Masdeu, J. C., Faridar, A. & Pascual, B.
10/20/20 → …
Project: Clinical Trial
-
-
PSLOT_Radiocephalic Fistulas.
Peden, E. K., Le, L., Lumsden, A. B. & Rahimi, M.
8/12/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix C - For CNM-Au8
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Madan, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Pownall, H. J., Rosales, C. & Gillard, B. K.
12/1/19 → 11/30/24
Project: Federal Funding Agencies
-
18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O., Pascual, B. & Roman, G. C.
10/29/19 → …
Project: Clinical Trial
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Pascual, B., Faridar, A. & Masdeu, J. C.
9/15/19 → 6/30/24
Project: Non Profit
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - Clinical Core
9/15/19 → 6/30/24
Project: Federal Funding Agencies
-
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Abraham, B. P., Fan, C. & Glassner, K.
2/11/19 → …
Project: Clinical Trial
-
Glutathione in Mild Cognitive Impairment
Masdeu, J. C., Faridar, A. & Pascual, B.
8/6/18 → …
Project: Clinical Trial
-
-
Corrona Inflammatory Bowel Disease (IBD) Registry
Abraham, B. P., Fan, C. & Glassner, K.
4/3/18 → …
Project: Clinical Trial